Management of asthma in the elderly patient

Clinical Interventions in Aging

Volumn 8, Issue , 2013, Pages 913-922

  Melani, Andrea S ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Asthma; Asthma control; Beta2 agonists; Elderly; Inhaled corticosteroids

Indexed keywords

ANTIASTHMATIC AGENT; BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; CYCLOSPORIN DERIVATIVE; FLUNISOLIDE; FLUTICASONE; FLUTICASONE FUROATE; FORMOTEROL; HANDIHALER; INDACATEROL; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR STIMULATING AGENT; LONG ACTING DRUG; MACROLIDE; METHOTREXATE; MOMETASONE FUROATE; MONTELUKAST; OMALIZUMAB; PREDNISOLONE; RESPIMAT; ROFLUMILAST; SALBUTAMOL; SHORT ACTING DRUG; TACROLIMUS; THEOPHYLLINE; TIOTROPIUM BROMIDE; TRIAMCINOLONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VILANTEROL;

ADD ON THERAPY; ADRENAL INSUFFICIENCY; AGE; AGED; ANAPHYLAXIS; ASTHMA; BRONCHIAL THERMOPLASTY; BRONCHOSCOPY; CATARACT; COMORBIDITY; DIABETES MELLITUS; DISEASE CONTROL; DISEASE EXACERBATION; DRUG DOSE COMPARISON; DRUG INTERACTION; DRUG MEGADOSE; EXERCISE; GASTRITIS; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HUMAN; HYPERTENSION; INJECTION SITE REACTION; LOW DRUG DOSE; METERED DOSE INHALER; MORBIDITY; MORTALITY; MUSCLE WEAKNESS; OSTEOPOROSIS; PATIENT CARE; PATIENT COMPLIANCE; PEPTIC ULCER; POLYPHARMACY; PRACTICE GUIDELINE; PSYCHOSIS; REVIEW; SKIN BRUISING; UNSPECIFIED SIDE EFFECT; VIRUS;

ASTHMA; ASTHMA CONTROL; BETA2-AGONISTS; ELDERLY; INHALED CORTICOSTEROIDS;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; AGED; AGED, 80 AND OVER; ANTI-ASTHMATIC AGENTS; ANTIBODIES, MONOCLONAL; ASTHMA; CHOLINERGIC ANTAGONISTS; COMORBIDITY; HUMANS; LEUKOTRIENE ANTAGONISTS; PRACTICE GUIDELINES AS TOPIC;

EID: 84880301617     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S33609     Document Type: Review

References (106)

1. National Heart, Lung, and Blood Institute; National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda: National Heart, Lung, and Blood Institute; 2007. Available from: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. Accessed March 31, 2013.
2. British Thoracic Society; Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. A national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network; 2012. Available from: http://www.sign.ac.uk/pdf/sign101.pdf. Accessed March 31, 2013.
3. Global Initiative for Asthma [homepage on the Internet]. Global strategy for asthma management and prevention [updated 2009]. Available from: http://www.ginasthma.org/guidelines-gina-report-global-strategy-for-asthma.html. Accessed March 31, 2013.
4. Lougheed MD, Leniere C, Ducharme FM; Canadian Thoracic Society Asthma Clinical Assemby. Canadian Thoracic Society 2012 Guideline update: diagnosis and management of asthma in preschoolers, children, and adults: executive summary. Can Respir J. 2012;19(6):e81-e88.
5. Jonas DE, Wines RCM, DelMonte M, et al; Oregon Health and Science University. Drug Class Review: Controller Medications for Asthma. Final Update 1 Report. 2011. Available from: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0032860/pdf/TOC.pdf. Accessed March 31, 2013.
6. Zureik M, Orehek J. Diagnosis and severity of asthma in the elderly: results of a large survey in 1,485 asthmatics recruited by lung specialists. Respiration. 2002;69(3):223-228.
7. Simpson CR, Sheikh A. Trends in the epidemiology of asthma in England: a national study of 333,294 patients. J R Soc Med. 2010;103(3):98-106.
8. Enright PL, McClelland RL, Newman AB, Gottlieb DJ, Lebowitz MD. Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group. Chest. 1999;116(3): 603-613.
9. Plaza V, Serra-Batlles J, Ferrer M, Morejón E. Quality of life and economic features in elderly asthmatics. Respiration. 2000;67(1):65-70.
10. Banerji A, Clark S, Afilalo M, Blanda MP, Cydulka RK, Camargo CA Jr. Prospective multicenter study of acute asthma in younger versus older adults presenting to the emergency department. J Am Geriatr Soc. 2006;54(1):48-55.
11. Hanania NA, King MJ, Braman SS, et al; Asthma in Elderly workshop participants. Asthma in the elderly: Current understanding and future research needs - a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol. 2011;128(Suppl 3):S4-S24.
12. Talreja N, Baptist AP. Effect of age on asthma control: results from the National Asthma Survey. Ann Allergy Asthma Immunol. 2011;106(1): 24-29.
13. Tsai CL, Delclos GL, Huang JS, Hanania NA, Camargo CA Jr. Agerelated differences in asthma outcomes in the United States, 1988-2006. Ann Allergy Asthma Immunol. 2013;110(4):240-246.
14. O'Byrne PM, Reddel HK, Eriksson G, et al. Measuring asthma control: a comparison of three classification systems. Eur Respir J. 2010;36(2):269-276.
15. Connolly MJ, Crowley JJ, Charan NB, Nielson CP, Vestal RE. Reduced subjective awareness of bronchoconstriction provoked by methacholine in elderly asthmatic and normal subjects as measured on a simple awareness scale. Thorax. 1992;47(6):410-413.
16. Ekici M, Apan A, Ekici A, Erdemoǧlu AK. Perception of bronchoconstriction in elderly asthmatics. J Asthma. 2001;38(8):691-696.
17. Goeman DP, O'Hehir RE, Jenkins C, Scharf SL, Douglass JA. 'You have to learn to live with it': a qualitative and quantitative study of older people with asthma. Clin Respir J. 2007;1(2):99-105.
18. Allen SC, Vassallo M, Khattab A. The threshold for sensing airflow resistance during tidal breathing rises in old age: implications for elderly patients with obstructive airways diseases. Age Ageing. 2009;38(5): 548-552.
19. Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet. 2010;376(9743):803-813.
20. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902-907.
21. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59-65.
22. Vollmer WM, Markson LE, O'Connor E, et al. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1647-1652.
23. Buist AS, Vollmer WM, Wilson SR, Frazier EA, Hayward AD. A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma. Am J Respir Crit Care Med. 2006;174(10): 1077-1087.
24. Columbo M, Wong B, Panettieri RA Jr, Rohr AS. Asthma in the elderly: the role of oxhaled nitric oxide measurements. Respir Med. 2013;107(5):785-787.
25. NAEPP Working Group Report. Considerations for Diagnosing and Managing Asthma in the Elderly. Bethesda: National Heart, Lung, and Blood Institute; 1996. Available from: http://msdh.ms.gov/msdhsite/_static/resources/2107.pdf. Accessed on March 20, 2013.
26. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med. 1998;157(3 Pt 2):S1-S53.
27. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch Intern Med. 1999;159(9):941-955.
28. Szefler SJ, Martin RJ, King TS, et al; Asthma Clinical Research Network of the National Heart Lung, and Blood Institute. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol. 2002;109(3):410-418.
29. Derendorf H, Nave R, Drollmann A, Cerasoli F, Wurst W. Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. Eur Respir J. 2006;28(5):1042-1050.
30. Melani AS. Nebulized corticosteroids in asthma and COPD. An Italian appraisal. Respir Care. 2012;57(7):1161-1174.
31. Price D, Martin RJ, Barnes N, et al. Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study. J Allergy Clin Immunol. 2010;126(3): 511-518.
32. Müller V, Gálffy G, Eszes N, et al. Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation. BMC Pulm Med. 2011;11:40.
33. Brusselle G, Peché R, Van den Brande P, Verhulst A, Hollanders W, Bruhwyler J. Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking status. Respir Med. 2012;106(6):811-819.
34. Rank MA, Hagan JB, Park MA, et al. The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids: A systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol. 2013;131(3):724-729.
35. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet. 2006;368(9537):804-813.
36. Thomas RA, Green RH, Brithling CE, et al. The influence of age on induced sputum differential cell counts in normal subjects. Chest. 2004;126(6):1811-1814.
37. Navaratnam P, Jayawant SS, Pedersen CA, Balkrishnan R. Asthma pharmacotherapy prescribing in the ambulatory population of the United States: evidence of nonadherence to national guidelines and implications for elderly people. J Am Geriatr Soc. 2008;56(7):1312-1317.
38. Sin DD, Tu JV. Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics. Eur Respir J. 2001;17(3):380-385.
39. Dolovich MB, Ahrens RC, Hess DR, et al; American College of Chest Physicians; American College of Asthma, Allergy, and Immunology. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest. 2005;127(1):335-371.
40. Pfeifer MA, Weinberg CR, Cook D, Best JD, Reenan A, Halter JB. Differential changes of autonomic nervous system function with age in man. Am J Med. 1983;75(2):249-258.
41. Connolly MJ, Crowley JJ, Charan NB, Nielson CP, Vestal RE. Impaired bronchodilator response to albuterol in healthy elderly men and women. Chest. 1995;108(2):401-406.
42. Sears MR, Taylor DR, Print CG, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet. 1990;336(8728):1391-1396.
43. Lazarus SC, Boushey HA, Fahy JV, et al; Asthma Clinical Research Network for the National Heart, Lung, and Blood Institute. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA. 2001;285(20):2583-2593.
44. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM; SMART Study Group. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006;129(1):15-26.
45. Bateman ED, Boushey HA, Bousquet J, et al; GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med. 2004; 170(8):836-844.
46. Stempel DA, Stoloff SW, Carranza Rosenzweig JR, Stanford RH, Ryskina KL, Legorreta AP. Adherence to asthma controller medication regimens. Respir Med. 2005;99(10):1263-1267.
47. Perrin K, Williams M, Wijesinghe M, James K, Weatherall M, Beasley R. Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting beta-agonist inhaler therapy in asthma. J Allergy Clin Immunol. 2010;126(3):505-510.
48. McMahon AW, Levenson MS, McEvoy BW, Mosholder AD, Murphy D. Age and risks of FDA-approved long-acting β2-adrenergic receptor agonists. Pediatrics. 2011;128(5):e1147-e1154.
49. Brozek JL, Kraft M, Krishnan JA, et al. Long-acting β2-agonist step-off in patients with controlled asthma. Arch Intern Med. 2012;172(18): 1365-1375.
50. Goeman DP, Jenkins CR, Crane MA, Bosnic-Anticevich SZ, Douglass JA. Unmet needs of older people with asthma: cross-sectional survey. J Asthma. 2011;48(9):865-875.
51. Chauhan BF, Ducharme FM. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database Syst Rev. 2012;5: CD002314.
52. Korenblat PE, Kemp JP, Scherger JE, Minkwitz MC, Mezzanotte W. Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience And Pharmacoepidemiology Trial (ACCEPT). Ann Allergy Asthma Immunol. 2000;84(2):217-225.
53. Price DB, Swern A, Tozzi CA, Philip G, Polos P. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy. 2006;61(6):737-742.
54. Lazarus SC, Chinchilli VM, Rollings NJ, et al; National Heart Lung and Blood Institute's Asthma Clinical Research Network. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med. 2007;175(8):783-790.
55. Ducharme FM, Lasserson TJ, Cates CJ. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma. Cochrane Database Syst Rev. 2011;(5):CD003137.
56. Tan R, Corren J. Omalizumab in the treatment of asthma. Expert Rev Respir Med. 2011;5(6):747-756.
57. Buhl R, Fox H, Blogg M, Reisner C. Add-on omalizumab therapy reduces clinically significant and severe asthma exacerbations, and improves FEV1 in patients with severe persistent allergic asthma irrespective of age. Eur Respir J. 2005;26(Suppl 49):48S, P418
58. Lowe PJ, Renard D. Omalizumab decreases IgE production in patients with allergic (IgE-mediated) asthma; PKPD analysis of a biomarker, total IgE. Br J Clin Pharmacol. 2011;72(2):306-320.
59. Cox L, Lieberman P, Wallace D, et al. American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Omalizumab-Associated Anaphylaxis Joint Task Force follow-up report. J Allergy Clin Immunol. 2011;128(1):210-212.
60. Tattersfield AE, Postma DS, Barnes PJ, et al. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med. 1999;160(2):594-599.
61. Ullah MI, Newman GB, Saunders KB. Influence of age on response to ipratropium and salbutamol in asthma. Thorax. 1981;36(7):523-529.
62. Lipworth BJ. Emerging role of long-acting muscarinic antagonists for asthma. Br J Clin Pharmacol. Epub March 28, 2013.
63. Singh S, Loke YK, Enright PL, Furberg CD. Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials. BMJ. 2011;342:d3215.
64. Simpson JL, Powell H, Boyle MJ, Scott RJ, Gibson PG. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med. 2008;177(2):148-155.
65. Sutherland ER, King TS, Icitovic N, et al; National Heart, Lung and Blood Institute's Asthma Clinical Research Network. A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol. 2010;126(4):747-753.
66. Brusselle GG, Vanderstichele C, Jordens P, et al. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial. Thorax. 2013;68(4):322-329.
67. Bateman ED, Izquierdo JL, Harnest U, et al. Efficacy and safety of roflumilast in the treatment of asthma. Ann Allergy Asthma Immunol. 2006;96(5):679-686.
68. Gildea TR, Khatri SB, Castro M. Bronchial thermoplasty: a new treatment for severe refractory asthma. Cleve Clin J Med. 2011;78(7): 477-485.
69. Slavin RG, Haselkorn T, Lee JH, Zheng B, Deniz Y, Wenzel SE; TENOR Study Group. Asthma in older adults: observations from the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study. Ann Allergy Asthma Immunol. 2006;96(3): 406-414.
70. Scichilone N, Callari A, Augugliaro G, Marchese M, Togias A, Bellia V. The impact of age on prevalence of positive skin prick tests and specific IgE tests. Respir Med. 2011;105(5):651-658.
71. Bozek A, Ignasiak B, Filipowska B, Jarzab J. House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis. Clin Exp Allergy. 2013;43(2):242-248.
72. Jackson DJ, Johnston SL. The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol. 2010;125(6):1178-1187.
73. Pesek R, Lockey R. Vaccination of adults with asthma and COPD. Allergy. 2011;66(1):25-31.
74. Centers for Disease Control and Prevention (CDC). Influenza vaccination and self-reported reasons for not receiving influenza vaccination among Medicare beneficiaries aged. or = 65 years - United States, 1991-2002. MMWR Morb Mortal Wkly Rep. 2004;53(43):1012-1015.
75. Bentayeb M, Simoni M, Baiz N, et al; Geriatric Study in Europe on Health Effects of Air Quality in Nursing Homes Group. Adverse respiratory effects of outdoor air pollution in the elderly. Int J Tuberc Lung Dis. 2012;16(9):1149-1161.
76. Boulet LP, FitzGerald JM, McIvor RA, Zimmerman S, Chapman KR. Influence of current or former smoking on asthma management and control. Can Respir J. 2008;15(5):275-279.
77. Tomlinson JE, McMahon AD, Chaudhuri R, Thompson JM, Wood SF, Thomson NC. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax. 2005;60(4): 282-287.
78. Chaudhuri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med. 2003;168(11):1308-1311.
79. Gellert C, Schöttker B, Brenner H. Smoking and all-cause mortality in older people: systematic review and meta-analysis. Arch Intern Med. 2012;172(11):837-844.
80. Tait RJ, Hulse GK, Waterreus A, et al. Effectiveness of a smoking cessation intervention in older adults. Addiction. 2007;102(1): 148-155.
81. Turner S, Eastwood P, Cook A, Jenkins S. Improvements in symptoms and quality of life following exercise training in older adults with moderate/severe persistent asthma. Respiration. 2011;81(4):302-310.
82. Boulet LP, Boulay MÈ. Asthma-related comorbidities. Expert Rev Respir Med. 2011;5(3):377-393.
83. Gershon AS, Guan J, Wang C, Victor JC, To T. Describing and quantifying asthma comorbidity: a population study. PLoS One. 2012;7(5): e34967.
84. Szczeklik A. Aspirin-induced asthma: a tribute to John Vane as a source of inspiration. Pharmacol Rep. 2010;62(3):526-529.
85. Ashrafian H, Violaris AG. Beta-blocker therapy of cardiovascular diseases in patients with bronchial asthma or COPD: the pro viewpoint. Prim Care Respir J. 2005;14(5):236-241.
86. Odeh M, Oliven A, Bassan H. Timolol eyedrop-induced fatal bronchospasm in an asthmatic patient. J Fam Pract. 1991;32(1):97-98.
87. Martin-García C, Hinojosa M, Berges P, Camacho E, García-Rodriguez R, Alfaya T. Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients. J Invest Allergol Clin Immunol. 2003;13(1):20-25.
88. Hanania NA, Singh S, El-Wali R, et al. The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm Pharmacol Ther. 2008;21(1):134-141.
89. Gibson PG, Powell H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev. 2003;(1):CD001117.
90. Schneider A, Körner T, Mehring M, Wensing M, Elwyn G, Szecsenyi J. Impact of age, health locus of control and psychological co-morbidity on patients' preferences for shared decision making in general practice. Patient Educ Couns. 2006;61(2):292-298.
91. Patel RR, Saltoun CA, Grammer LC. Improving asthma care for the elderly: a randomized controlled trial using a simple telephone intervention. J Asthma. 2009;46(1):30-35.
92. Baptist AP, Ross JA, Yang Y, Song PX, Clark NM. A randomized controlled trial of a self-regulation intervention for older adults with asthma. J Am Geriatr Soc. 2013;61(5):747-753.
93. Goeman DP, Sanci LA, Scharf SL, et al. Improving general practice consultations for older people with asthma: a cluster randomized control trial. Med J Aust. 2009;191(2):113-117.
94. Bozek A, Jarzab J. Adherence to asthma therapy in elderly patients. J Asthma. 2010;47(2):162-165.
95. Wilson SR, Strub P, Buist AS, et al; Better Outcomes of Asthma Treatment (BOAT) Study Group. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med. 2010;181(6):566-577.
96. World Health Organization. Adherence to Long-term Therapies: Evidence for Action. Geneva: World Health Organization; 2003. Available from: http://www.who.int/chp/knowledge/publications/adherence_report/en/. Accessed March 20, 2013.
97. Harrison B, Stephenson P, Mohan G, Nasser S. An ongoing Confidential Enquiry into asthma deaths in the Eastern Region of the UK, 2001-2003. Prim Care Respir J. 2005;14(6):303-313.
98. Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114(6):1288-1293.
99. Williams LK, Peterson EL, Wells K, et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol. 2011;128(6):1185-1191.
100. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101-2107.
101. Krauskopf KA, Sofianou A, Goel MS, et al. Depressive symptoms, low adherence, and poor asthma outcomes in the elderly. J Asthma. 2013;50(3):260-266.
102. Sestini P, Cappiello V, Aliani M, et al; Associazione Italiana Pneumologi Ospedalieri Educational Group. Prescription bias and factors associated with improper use of inhalers. J Aerosol Med. 2006;19(2):127-136.
103. Melani AS, Bonavia M, Cilenti V, et al; Gruppo Educazionale Associazione Italiana Pneumologi Ospedalieri. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105(6):930-938.
104. Travers J, Marsh S, Williams M, et al. External validity of randomized controlled trials in asthma: to whom do the results of the trials apply? Thorax. 2007;62(3):219-223.
105. Krishnan JA, Schatz M, Apter AJ. A call for action: Comparative effectiveness research in asthma. J Allergy Clin Immunol. 2011;127(1): 123-127.
106. Price D, Hillyer EV, van der Molen T. Efficacy versus effectiveness trials: informing guidelines for asthma management. Curr Opin Allergy Clin Immunol. 2013;13(1):50-57